Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Multiple Sclerosis

  Free Subscription

Articles published in Int J Neurosci

Retrieve available abstracts of 19 articles:
HTML format

Single Articles

    July 2021
    Understanding Visual-Spatial Perceptual Deficits in Individuals with Multiple Sclerosis: An Analysis of Patient Performance on the Hooper Visual Organization Test and Visual Form Discrimination.
    Int J Neurosci. 2021 Jul 13:1-9. doi: 10.1080/00207454.2021.1954642.
    PubMed     Abstract available

    February 2021
  2. DOSKAS T, Vavougios DG, Karampetsou P, Kormas C, et al
    Neurocognitive Impairment and Social Cognition in Multiple Sclerosis.
    Int J Neurosci. 2021 Feb 2:1-26. doi: 10.1080/00207454.2021.1879066.
    PubMed     Abstract available

    January 2021
  3. YAZDANPANAH M, Jalilian N, Abdollah Zadeh R, Sahraian MA, et al
    Investigating the association of polymorphisms of ANKRD55 and MMEL1 with susceptibility to multiple sclerosis in Iranian population.
    Int J Neurosci. 2021 Jan 24:1-6. doi: 10.1080/00207454.2020.1860964.
    PubMed     Abstract available

    October 2020
  4. JANKOVSKA E, Lipcseyova D, Svrdlikova M, Pavelcova M, et al
    Quantitative proteomic analysis of cerebrospinal fluid of women newly diagnosed with multiple sclerosis.
    Int J Neurosci. 2020 Oct 15:1-17. doi: 10.1080/00207454.2020.1837801.
    PubMed     Abstract available

  5. BATUM M, Kisabay Ak A, Cetin G, Celebi HBG, et al
    Coincidental Occurance of Episodic Ataxia and Multiple Sclerosis: A Case Report and Review of the Literature.
    Int J Neurosci. 2020 Oct 12:1-7. doi: 10.1080/00207454.2020.1835896.
    PubMed     Abstract available

    September 2020
  6. SURMELI R, Surmeli M, Yalcin AD, Sahin Yilmaz AA, et al
    Multiple Sclerosis Attack Case Presenting with Pseudo-Vestibular Neuritis.
    Int J Neurosci. 2020 Sep 28:1-5. doi: 10.1080/00207454.2020.1829617.
    PubMed     Abstract available

  7. NAJAFI S, Beladi Moghadam N, Saadat P, Noorbakhsh SM, et al
    A controlled, randomized phase II clinical trial for efficacy and safety evaluation of mannuronic acid in secondary progressive form of multiple sclerosis.
    Int J Neurosci. 2020 Sep 2:1-12. doi: 10.1080/00207454.2020.1818741.
    PubMed     Abstract available

    August 2020
  8. LABIB DA, Ashmawy I, Elmazny A, Helmy H, et al
    Toll-like receptors 2 and 4 expression on peripheral blood lymphocytes and neutrophils of Egyptian multiple sclerosis patients.
    Int J Neurosci. 2020 Aug 26:1-5. doi: 10.1080/00207454.2020.1812601.
    PubMed     Abstract available

  9. ANDALORO A, Russo M, Pastura C, Sessa E, et al
    Is there a correlation between dyslipidemia and cognitive impairment in patients with multiple sclerosis?
    Int J Neurosci. 2020 Aug 7:1-13. doi: 10.1080/00207454.2020.1807980.
    PubMed     Abstract available

    June 2020
  10. BRAUN T, Juenemann M, Dornes K, El-Shazly J, et al
    BAFF serum and CSF levels in patients with multiple sclerosis and infectious nervous system diseases.
    Int J Neurosci. 2020 Jun 30:1-6. doi: 10.1080/00207454.2020.1784167.
    PubMed     Abstract available

  11. ORTIZ GG, Mireles-Ramirez MA, Pacheco-Moises FP, Ramirez-Jirano LJ, et al
    Are Electrophysiological and Oligodendrocyte Alterations an Element in the Development of Multiple Sclerosis at the Same Time as or Before the Immune Response?
    Int J Neurosci. 2020 Jun 22:1-15. doi: 10.1080/00207454.2020.1786087.
    PubMed     Abstract available

    April 2020
  12. MOUSAVI-SHIRAZI-FARD Z, Mazloom Z, Izadi S, Fararouei M, et al
    The effects of modified anti-inflammatory diet on fatigue, quality of life,and inflammatory biomarkers in relapsing-remitting multiple sclerosis patients: A randomized clinical trial.
    Int J Neurosci. 2020 Apr 6:1-12. doi: 10.1080/00207454.2020.1750398.
    PubMed     Abstract available

    February 2020
  13. JAMEBOZORGI K, Rostami D, Pormasoumi H, Taghizadeh E, et al
    Epigenetic aspects of multiple sclerosis and future therapeutic options.
    Int J Neurosci. 2020 Feb 20:1-15. doi: 10.1080/00207454.2020.1732974.
    PubMed     Abstract available

  14. MEUTH SG, Henze T, Essner U, Trompke C, et al
    Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial.
    Int J Neurosci. 2020 Feb 17:1-15. doi: 10.1080/00207454.2020.1730832.
    PubMed     Abstract available

    December 2019
  15. JAFARINIA M, Sadeghi E, Alsahebfosoul F, Etemadifar M, et al
    Evaluation of plasma Osteopontin level in relapsing- remitting multiple sclerosis patients compared to healthy subjects in Isfahan Province.
    Int J Neurosci. 2019 Dec 3:1-6. doi: 10.1080/00207454.2019.1694925.
    PubMed     Abstract available

  16. SHAKER OG, Golam RM, Ayoub S, Daker LI, et al
    Correlation between LincR-Gng2-5'and LincR-Epas1-3'as with the severity of multiple sclerosis in Egyptian patients.
    Int J Neurosci. 2019 Dec 2:1-7. doi: 10.1080/00207454.2019.1695610.
    PubMed     Abstract available

  17. RAJIZADEH MA, Sheibani V, Bejeshk MA, Mohtashami Borzadaran F, et al
    The effects of high intensity exercise on learning and memory impairments followed by combination of sleep deprivation and demyelination induced by etidium bromide.
    Int J Neurosci. 2019;129:1166-1178.
    PubMed     Abstract available

    November 2019
  18. MORADI M, Gharesouran J, Ghafouri-Fard S, Noroozi R, et al
    Role of NR3C1 and GAS5 genes polymorphisms in Multiple Sclerosis.
    Int J Neurosci. 2019 Nov 14:1-10. doi: 10.1080/00207454.2019.1694019.
    PubMed     Abstract available

    October 2019
    Towards a Comprehensive Etiopathogenetic and Pathophysiological Theory of Multiple Sclerosis.
    Int J Neurosci. 2019 Oct 7:1-41. doi: 10.1080/00207454.2019.1677648.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.